Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
U.S. Government Seeks Dismissal of Camp Lejeune Kidney Cancer Lawsuits Motion for summary judgment comes as more than 500,000 claims continue to move forward involving various injuries linked to contaminated water at Camp Lejeune between the mid-1950s and late-1980s. September 15, 2025 Irvin Jackson Add Your Comments The U.S. government has asked a group of federal judges to grant a summary judgment motion that may dismiss Camp Lejeune kidney cancer lawsuits, claiming the plaintiffs’ expert opinions linking water contamination at the U.S. Marine training base to the disease are unreliable and inadmissible. In August 2022, the Camp Lejeune Justice Act (CLJA) was signed into law, which provided a two-year filing window for individuals who lived, served or worked on the North Carolina military base from the mid-1950s to late 1980s to seek financial compensation for various types of cancer and other ailments linked to toxic chemicals that contaminated the base’s water supply. After that window closed last summer, the government faced nearly 500,000 administrative claims and lawsuits, involving dozens of different injuries believed to be caused by exposure to the contaminated Camp Lejeune water. Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More The litigation is currently being overseen by four different U.S. District Judges in the Eastern District of North Carolina, including Richard E. Myers II, Terrence W. Boyle, Louise W. Flanagan and James C. Dever III. While the U.S. government announced an elective settlement option for Camp Lejeune lawsuits in September 2023, many claims remain unresolved given the minimal payouts offered for many injuries. To help gauge how the court may respond to certain evidence and testimony that will be presented throughout thousands of claims, the four judges are preparing groups of claims involving different categories of injuries for early trial dates. In October 2023, the Court established a Camp Lejeune Lawsuit Track 1 criteria, and the parties selected a group of 100 cases to go through early discovery involving the following five categories of injuries: Bladder cancer Kidney cancer Leukemia Parkinson’s disease Non-Hodgkin’s lymphoma The Court then directed the parties to narrow the list to a group of 25 claims that will be eligible for trial, including five cases from each of the five injury categories, with plaintiffs selecting three of the claims and the U.S. government selecting the other two. U.S. Seeks Camp Lejeune Summary Judgments On September 10, the United States government filed a Motion for Summary Judgment (PDF), asking that the lawsuits of the five plaintiffs selected to represent kidney cancer claims all be thrown out. The government argues that the plaintiffs have failed to demonstrate that their kidney cancer was caused by exposure to perchloroethylene, benzene and vinyl chloride in Camp Lejeune drinking water. “As outlined in these Motions to Exclude, because Plaintiffs’ experts’ analyses are unreliable and their opinions inadmissible, Plaintiffs do not have sufficient evidence to prove that their alleged exposures to benzene, Camp Lejeune water caused their kidney cancers as either a matter of general causation or specific causation.” – Memorandum in Support of U.S.’s Motion for Summary Judgment The argument comes despite the government’s earlier promise that plaintiffs only needed to have served, worked or lived on Camp Lejeune during the decades when its water was contaminated and had a kidney cancer diagnosis to qualify for compensation. However, now the government argues that reliable expert testimony is needed to prove causation for kidney cancer, despite the fact that avoiding those kinds of requirements decades after the exposures occur was a major impetus for the CLJA. Regardless of whether the kidney injury claims survive the motion, the court will continue preparing to hold the rest of the bellwether trials. Even though the outcome of these early bellwether trials will not have a binding impact on other claims in the litigation, they will be closely watched by lawyers involved in the cases, as the average amounts of any Camp Lejeune lawsuit payouts awarded may help the parties in global settlement negotiations for various types of injuries. Sign up for more legal news that could affect you or your family. Tags: Camp Lejeune, Camp Lejeune Settlement, Department of The Navy, Lawsuits, North Carolina, Veteran Affairs, Veterans Image Credit: Militarist / Shutterstock.com Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Camp Lejeune Stories Trichloroethylene Exposure Linked to Parkinson’s Disease Risk: Study October 8, 2025 Court Urged To Press Forward With Camp Lejeune Lawsuit Deadlines During Government Shutdown October 6, 2025 Camp Lejeune Settlement Update Outlines Plans To Resolve Water Contamination Lawsuits by End of 2025 March 26, 2025 1 Comments Brian September 16, 2025 The ATSDR morbidity study report shows the contaminated drinking water from camp lejeune is associated with bladder cancer, kidney cancer, and kidney disease. But this really does not even matter as this government has no interest in paying for ANY health issues associated with camp lejeune! I have been dealing with numerous health problems associated with the drinking water. (Non-hodgkin-lymphoma, MDS, prostrate cancer, and years of health issues but the government is about washing their hands of their responsibility. And any costs that should have been covered by the VA for my heath issues have been billed to my insurance company. The only benefit to me was that they did not bill me the co-pay for the cancer they cause. LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025) Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)
Court Urged To Press Forward With Camp Lejeune Lawsuit Deadlines During Government Shutdown October 6, 2025
Camp Lejeune Settlement Update Outlines Plans To Resolve Water Contamination Lawsuits by End of 2025 March 26, 2025
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)